Metformin Inhibits the Development, and Promotes the Resensitization, of Treatment-Resistant Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0187191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells

Analytical Cellular Pathology
Molecular MedicineCell BiologyCancer ResearchForensic MedicineMedicinePathology
2018English

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Metformin as an Adjuvant in Breast Cancer Treatment

SAGE Open Medicine
Medicine
2019English

Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis

Current Pharmacology Reports
BiochemistryDrug DiscoveryGeneticsPharmacology
2015English

Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2007English

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases

Cancers
Cancer ResearchOncology
2020English

Loss of COX5B Inhibits Proliferation and Promotes Senescence via Mitochondrial Dysfunction in Breast Cancer

Oncotarget
Oncology
2015English

TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer Through Activation of Axl Kinase

Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy